417 related articles for article (PubMed ID: 22755330)
41. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
Tartarone A; Lerose R
Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
[TBL] [Abstract][Full Text] [Related]
42. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
[TBL] [Abstract][Full Text] [Related]
43. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
44. Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus.
Pahk R; Azu MC; Taira BR; Sandoval S
Clin Exp Dermatol; 2009 Dec; 34(8):e775-7. PubMed ID: 19778313
[TBL] [Abstract][Full Text] [Related]
45. Toxic epidermal necrolysis syndrome--management and case report.
Najem JC; Raphael N; Ghanime G; Karam R; Tohme H; Moukarzel Z; Achy J
Middle East J Anaesthesiol; 2004 Oct; 17(6):1079-91. PubMed ID: 15651515
[TBL] [Abstract][Full Text] [Related]
46. Toxic Epidermal Necrolysis During Dronedarone Treatment: First Report of a Severe Serious Adverse Event Of A New Antiarrhythmic Drug.
Gecks T; Prochnau D; Franz M; Jung C; Kühnert H; Schliemann S; Figulla HR
Cardiovasc Toxicol; 2015 Oct; 15(4):399-401. PubMed ID: 25588686
[TBL] [Abstract][Full Text] [Related]
47. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons.
Prandota J
Am J Ther; 2002; 9(2):149-56. PubMed ID: 11897929
[TBL] [Abstract][Full Text] [Related]
48. Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction?
Sachs B; Fischer-Barth W; Erdmann S; Merk HF; Seebeck J
Allergy; 2007 Aug; 62(8):877-83. PubMed ID: 17620064
[TBL] [Abstract][Full Text] [Related]
49. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
[TBL] [Abstract][Full Text] [Related]
50. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
51. Phenytoin induced Stevens-Johnson Syndrome-toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-old Neurosurgical Patient: A Rare Case Report.
Rathinam KK; Sabarathinam S; Nuthalapati P; Mahalingam VT
Curr Drug Res Rev; 2022; 14(1):80-83. PubMed ID: 34225642
[TBL] [Abstract][Full Text] [Related]
52. [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
Bellakhal S; Ben Kaab B; Teyeb Z; Souissi A; Derbel F; Douggui MH
Pathol Biol (Paris); 2015 Sep; 63(4-5):222-3. PubMed ID: 26088436
[TBL] [Abstract][Full Text] [Related]
53. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
[TBL] [Abstract][Full Text] [Related]
54. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
Roujeau JC
Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
[TBL] [Abstract][Full Text] [Related]
55. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
56. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
Hockett KC
Clin J Oncol Nurs; 2004 Feb; 8(1):27-30, 55. PubMed ID: 14983759
[TBL] [Abstract][Full Text] [Related]
57. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
Jezierska-Krupa B; Hyla-Klekot L
Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
[TBL] [Abstract][Full Text] [Related]
58. [Severe cutaneous drug reactions to misused griseofulvin: 2 cases].
Le Guern A; Kerrad I; Oehler E
Ann Dermatol Venereol; 2016 Mar; 143(3):219-22. PubMed ID: 26831946
[TBL] [Abstract][Full Text] [Related]
59. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
Oliveira A; Sanches M; Selores M
Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510
[TBL] [Abstract][Full Text] [Related]
60. Culprit drug of toxic epidermal necrolysis in a child: A case report.
Kunikata A; Matsushita S; Oishi Y; Tsuchiya K
Pediatr Int; 2021 Feb; 63(2):217-218. PubMed ID: 33547836
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
